Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
FDA's Blood Products Advisory Committee will meet July 20 to discuss clinical and surrogate endpoints for evaluating efficacy of alpha-1 proteinase inhibitors to treat alpha-antitrypsin (AAT) deficien...